Global Pharmaceuticals & Biotech Most Popular Stocks

Arterra Bioscience

Market Cap: €18.2m

A research-based biotech company, engages in the research and development of various ingredients and natural solutions.

Cingulate

Market Cap: US$21.2m

A biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.

Active Biotech

Market Cap: SEK 199.0m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

MediPharm Labs

Market Cap: CA$29.5m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Avicanna

Market Cap: CA$29.5m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.

TaiwanJ Pharmaceuticals

Market Cap: NT$641.0m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

Tissue Regenix Group

Market Cap: UK£15.7m

A medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally.

Aptamer Sciences

Market Cap: ₩29.6b

A bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms.

Panchsheel Organics

Market Cap: ₹1.8b

Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.

Lisata Therapeutics

Market Cap: US$20.7m

A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.

ProMIS Neurosciences

Market Cap: US$20.7m

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.

Enorama Pharma

Market Cap: SEK 193.9m

A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.

Daesung Microbiological Labs

Market Cap: ₩29.0b

Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.

Curis

Market Cap: US$20.5m

A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.

Reviva Pharmaceuticals Holdings

Market Cap: US$20.5m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

Pharmigene

Market Cap: NT$623.2m

Designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.

OncoSil Medical

Market Cap: AU$31.2m

A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.

Cell Source

Market Cap: US$20.4m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

Finch Therapeutics Group

Market Cap: US$20.2m

A clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.

NFL Biosciences

Market Cap: €17.1m

A biotechnology company, engages in the development of botanical drugs in France.

Astonea Labs

Market Cap: ₹1.8b

Manufactures and markets pharmaceutical and cosmetic products under the Glow Up and Regero brand names in India and internationally.

Coral Laboratories

Market Cap: ₹1.8b

Manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.

Optimi Health

Market Cap: CA$27.5m

Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.

Allarity Therapeutics

Market Cap: US$19.7m

A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.

Citius Pharmaceuticals

Market Cap: US$19.6m

A biopharmaceutical company, focuses on the development and commercialization of critical care products.

Harvard Bioscience

Market Cap: US$19.6m

Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.

Clearside Biomedical

Market Cap: US$19.5m

A biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

HLB SCIENCE

Market Cap: ₩27.4b

Develops biological drugs with MoA to infectious diseases.

WOOJUNG BIO

Market Cap: ₩27.4b

Provides non-clinical research agency services.

Synlogic

Market Cap: US$19.4m

A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.

Read-Gene

Market Cap: zł70.7m

Engages in the detection, prevention, and treatment of various types of cancer.

SLS BIO

Market Cap: ₩26.9b

Develops diagnostic technologies in South Korea.

Kimia Biosciences

Market Cap: ₹1.7b

Manufactures and sells active pharmaceutical ingredients (APIs) in India.

Curanex Pharmaceuticals

Market Cap: US$19.2m

A developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.

Voyageur Pharmaceuticals

Market Cap: CA$26.8m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

WooGene B&G

Market Cap: ₩27.0b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.